Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.11, 2013-11, pp. : 1023-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Live Recombinant Vaccine Candidates Against Tuberculosis

By Hess Jürgen Kaufmann Stefan H. E.

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 12, 2001-12 ,pp. : 77-78

Informa Healthcare

Access to resources Recommend Favorite

Development of Live Recombinant Vaccine Candidates Against Tuberculosis

By Hess Jürgen Kaufmann Stefan H. E.

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 10, 2001-10 ,pp. : 723-724

Informa Healthcare

Access to resources Recommend Favorite

The Importance of Precise Documentation of Vaccination by Physicians and Vaccine Providers

Current Drug Safety, Vol. 10, Iss. 1, 2015-01 ,pp. : 27-30

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Vaccination for HIV-1 and SIV

Intervirology, Vol. 43, Iss. 4-6, 2001-02 ,pp. : 282-287

Karger

Access to resources Recommend Favorite

Leishmaniasis

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 3, 2015-03 ,pp. : 191-201

John Wiley & Sons Inc

Access to resources Recommend Favorite